- Home
- ELDN vs NXDT Comparison
ELDN vs NXDT Comparison
Compare ELDN & NXDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- NXDT
- Stock Information
- Founded
- ELDN 2004
- NXDT 2012
- Country
- ELDN United States
- NXDT United States
- Employees
- ELDN N/A
- NXDT N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- NXDT Investment Managers
- Sector
- ELDN Health Care
- NXDT Finance
- Exchange
- ELDN Nasdaq
- NXDT Nasdaq
- Market Cap
- ELDN 178.4M
- NXDT 156.8M
- IPO Year
- ELDN N/A
- NXDT N/A
- Fundamental
- Price
- ELDN $3.17
- NXDT $3.49
- Analyst Decision
- ELDN Strong Buy
- NXDT
- Analyst Count
- ELDN 1
- NXDT 0
- Target Price
- ELDN $16.00
- NXDT N/A
- AVG Volume (30 Days)
- ELDN 150.4K
- NXDT 133.6K
- Earning Date
- ELDN 05-20-2025
- NXDT 01-01-0001
- Dividend Yield
- ELDN N/A
- NXDT 9.66%
- EPS Growth
- ELDN N/A
- NXDT N/A
- EPS
- ELDN N/A
- NXDT 0.99
- Revenue
- ELDN N/A
- NXDT N/A
- Revenue This Year
- ELDN N/A
- NXDT N/A
- Revenue Next Year
- ELDN N/A
- NXDT N/A
- P/E Ratio
- ELDN N/A
- NXDT $6.41
- Revenue Growth
- ELDN N/A
- NXDT N/A
- 52 Week Low
- ELDN $2.00
- NXDT $5.89
- 52 Week High
- ELDN $5.54
- NXDT $13.07
- Technical
- Relative Strength Index (RSI)
- ELDN 48.82
- NXDT 40.92
- Support Level
- ELDN $2.85
- NXDT $3.41
- Resistance Level
- ELDN $3.51
- NXDT $3.70
- Average True Range (ATR)
- ELDN 0.25
- NXDT 0.14
- MACD
- ELDN 0.01
- NXDT 0.01
- Stochastic Oscillator
- ELDN 45.07
- NXDT 16.67
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.